137 related articles for article (PubMed ID: 8713613)
1. [Aminosidine in the treatment of mucocutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis].
Romero GA; Lessa HA; Macêdo V; de Carvalho EM; de Magalhães AV; Orge M de la G; de Abreu MV; Marsden PD
Rev Soc Bras Med Trop; 1996; 29(2):215-6. PubMed ID: 8713613
[No Abstract] [Full Text] [Related]
2. [Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
Romero GA; Lessa HA; Macêdo VO; Carvalho EM; Barral A; Magalhães AV; Orge MG; Abreu MV; Marsden PD
Rev Soc Bras Med Trop; 1996; 29(6):557-65. PubMed ID: 9011880
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
[No Abstract] [Full Text] [Related]
4. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Rezzano S; Armas JA; Moreno G; Scorza JV
Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698
[No Abstract] [Full Text] [Related]
5. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.
Marsden PD
Rev Soc Bras Med Trop; 1994; 27(2):93-101. PubMed ID: 8073158
[TBL] [Abstract][Full Text] [Related]
6. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
7. Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.
Llanos-Cuentas A; Echevarria J; Seas C; Chang E; Cruz M; Alvarez E; Rosales E; Campos P; Bryceson A
Am J Trop Med Hyg; 2007 Jun; 76(6):1128-31. PubMed ID: 17556623
[TBL] [Abstract][Full Text] [Related]
8. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow-up].
Romero GA; Lessa HA; Orge MG; Macêdo VO; Marsden PD
Rev Soc Bras Med Trop; 1998; 31(6):511-6. PubMed ID: 9859693
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
11. [Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
Iguermia S; Harmouche T; Mikou O; Amarti A; Mernissi FZ
Med Mal Infect; 2011 Jan; 41(1):47-8. PubMed ID: 20947275
[No Abstract] [Full Text] [Related]
12. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
Adaui V; Lye LF; Akopyants NS; Zimic M; Llanos-Cuentas A; Garcia L; Maes I; De Doncker S; Dobson DE; Arevalo J; Dujardin JC; Beverley SM
J Infect Dis; 2016 Jan; 213(1):112-21. PubMed ID: 26123565
[TBL] [Abstract][Full Text] [Related]
13. [Experimental chemotherapy in hamsters, using paromomycin against 2 isolates of Leishmania mexicana and Leishmania braziliensis].
Rezzano S; Moreno G; Scorza JV
Rev Cubana Med Trop; 1982; 34(1):34-45. PubMed ID: 6750713
[No Abstract] [Full Text] [Related]
14. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
[TBL] [Abstract][Full Text] [Related]
15. Treatment of New World cutaneous and mucosal leishmaniases.
Berman JD
Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
[TBL] [Abstract][Full Text] [Related]
16. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
Hepburn NC; Tidman MJ; Hunter JA
Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
[TBL] [Abstract][Full Text] [Related]
17. Mucosal leishmaniasis presenting as sinusitis and optic neuropathy.
Huna-Baron R; Warren FA; Miller W; Jacobs J; Green J; Kupersmith MJ
Arch Ophthalmol; 2000 Jun; 118(6):852-4. PubMed ID: 10865330
[No Abstract] [Full Text] [Related]
18. Immunological selection for Leishmania (Viannia) braziliensis antigens.
Cuba Cuba CA; Ogunkolade W; Howard MK; Miles MA
Ann Trop Med Parasitol; 2001 Jul; 95(5):473-83. PubMed ID: 11487369
[TBL] [Abstract][Full Text] [Related]
19. Mucosal leishmaniasis . Current scenario and prospects for treatment.
Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
[TBL] [Abstract][Full Text] [Related]
20. [An evolutionary study of mucosal leishmaniasis (a 7- to 17-year follow-up) due to Leishmania (Viannia) braziliensis in Tres Braços, Bahia].
de Oliveira MR; Macêdo Vde O; de Carvalho EM; Barral A; Marotti JG; Bittencourt A; de Abreu MV; Orge M de La G; Lessa Hde A; Marsden PD
Rev Soc Bras Med Trop; 1995; 28(4):325-32. PubMed ID: 8668831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
